13D Filings
VOR BIOPHARMA INC.
VOR
Amendment
Ownership

29.10%

Total Shares

36,884,567

Issuer CIK

1817229

CUSIP

929033108

Event Date

Aug 26, 2025

Accepted

Aug 29, 2025, 06:30 PM

Reporting Persons (2)
Joint Filing

This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.

NameType% of ClassAggregateSole VotingShared Voting
Reprogrammed Interchange LLC
Other
29.10%36,884,567036,884,567
Reid Hoffman
Individual
29.10%36,884,567036,884,567
Disclosure Items (5)

Security Title

Common Stock, par value $.0001 per share

Issuer Name

VOR BIOPHARMA INC.

Issuer Address

100 Cambridgepark Drive, Suite 101, Cambridge, MA, 02140

Not applicable.

Item 4 of Schedule 13D is hereby amended and supplemented as follows: From August 25, 2025 through August 28, 2025, Reprogrammed Interchange LLC sold the following shares of Vor Biopharma Inc. in open market transactions, resulting in a decrease in the number of shares of Common Stock beneficially owned by the Reporting Persons by more than one percent of the outsanding shares of Common Stock of the Issuer. 1. 387,346 shares on August 25, 2025, at a weighted average per share sale price of $2.1163. 2. 284,190 shares on August 26, 2025, at a weighted average per share sale price of $2.0808. 3. 611,647 shares on August 27, 2025, at a weighted average per share sale price of $2.0053. 4. 806,351 shares on August 28, 2025, at a weighted average per share sale price of $2.0115.

Percentage of Class

The information contained in rows 7, 8, 9, 10, 11 and 13 on each of the cover pages of this Amendment No. 1 to the Schedule 13D, and the information set forth or incorporated in Items 2, 3, 4, 6 and 7, is incorporated by reference in its entirety into this Item 5.

Number of Shares

Regarding the number of shares as to which such person has: (i) sole power to vote or to direct the vote: See line 7 of cover sheets (ii) shared power to vote or to direct the vote: See line 8 of cover sheets (iii) sole power to dispose or to direct the disposition: See line 9 of cover sheets (iv) shared power to dispose or to direct the disposition: See line 10 of cover sheets.

Transactions

Except as set forth in Item 4 above, none of the Reporting Persons has effected any transactions in the Common Stock of the Issuer during the last 60 days.

Shareholders

Not applicable.

Date of 5% Ownership

Not applicable.

Not applicable.

VOR BIOPHARMA INC. — Schedule 13D | 13D Filings